ECS BOTANICS HOLDINGS LTD (ECS)

---

AI Coverage Rating: Active

ASX AI Signals has generated 3 signal for ECS during the last 90 days, indicating active trading activity and ongoing AI monitoring

Latest ECS Signals
17/06/2026	SELL
15/05/2026	BUY
14/04/2026	SELL
ECS Share Price
Current Price	$0.005
52 Week High	$0.010
52 Week Low:	$0.003
Trading at (% of 52 Week High)	50.00%

Business Overview

ECS Botanics Holdings Ltd (ASX: ECS) is an Australian company focused on the cultivation and manufacturing of medicinal cannabis products. The company operates in the healthcare sector, producing cannabinoid-based therapies for various medical conditions. ECS Botanics also engages in research and development to expand its product offerings.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The SELL recommendation for ECS BOTANICS HOLDINGS LTD is supported by weak price performance and potential liquidity concerns at the current low price level. However, the confidence is moderated by limited publicly available financial data and market volatility typical of micro-cap stocks.

Latest  ECS BOTANICS HOLDINGS LTD(ECS)   News